fbpx
 +1 386-243-9402 MON – FRI : 09:00 AM – 05:00 PM

Healthcare Common Sense: What Should Congress and the President Do?

Written: March 10, 2017Edited and Republished: October 23, 2021 The following article was published in LinkedIn four and a half years ago. Except for price transparency, which has not yet been fully complied with, not much has happened. Americans are struggling to pay the continually increasing cost of drugs and Congress continues to be the […]

Medicare to Negotiate with Pharmaceutical Industry

In March 2015, Health Attitude: Unraveling and Solving the Complexities of Healthcare was published. One of the recommendations made in the book, to address the spiraling healthcare cost for Americans, was to allow Medicare to negotiate the price of drugs. It was a lone voice at the time, but since then more and more people, including the […]

Big Changes Coming to Healthcare

Last week, the new Health and Human Services (HHS) Secretary, Alex Azar, said, “Change is possible, change is necessary, and change is coming.” I hope so. Change is desperately needed. It remains to be seen if the federal government can make the changes needed and make them fast enough. The biggest barrier is Congress. HHS […]

Corrupt Congress

Congress not only indirectly raised the cost of healthcare by not allowing Medicare to negotiate drug prices, but also in at least one case, it raised the cost of drugs through a pinpoint piece of legislation. The New York Times reported a provision buried in the “fiscal cliff” bill passed in January 2013 gave Amgen, […]

Big Pharma and Politics

At a rally in Kentucky, President Donald Trump said drug prices were “outrageous”. The next day, according to Kaiser Health News, the pharmaceutical industry donated more money to political campaigns than any other day this year. On March 21, eight pharma political action committees made 137 contributions to 77 politicians totaling nearly $280,000. Both Republicans and […]